Studies have shown that KLF4 acts as a tumor suppressor in colorectal cancer, gastric cancer, and bladder cancer [10–12] while playing an oncogenic role in breast cancer and skin cancer [13, 14]. This evidence concerns the gene KLF4 and breast carcinoma.